Almost everything we know about how to diagnose and treat cancer today was learned through the participation of people just like you. You can make a difference for future cancer patients by taking part in a clinical trial.
Your provider will discuss whether a clinical trial is available to you. Enrolling is your choice. You may choose to take part or not and are free to leave at any time.
See our open cancer clinical trials below. For more information, including how to enroll, please call 609-677-7735.
To learn more about clinical trials, visit the National Cancer Institute site.
Active Clinical Trials
Brain Cancer | Breast Cancer | Genitourinary Cancer | Gastrointestinal Cancer | Head & Neck Cancer | Multiple Disease Sites | Prostate Cancer
Brain Cancer
CCTG-CE.7
Category
Brain Cancer
Full Name
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5-15 Brain Metastases
Brief Description
A Phase III Trial of Stereotactic Radiosurgery Compared with Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) plus Memantine for 5 – 15 brain metastases
Sponsor
NCI Sponsored
ClinicalTrials.gov ID NCT03550391
View on Clinical Trials.gov
|
|
|
Breast Cancer
S2010
Category
Breast Cancer
Full Name
Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study
Brief Description
A Randomized Phase III Trial Comparing Active Symptom Monitoring Plus Patient Education Versus Patient Education Alone to Improve Persistence With Endocrine Therapy in Young Women With Stage I-III Breast Cancer (ASPEN)
Sponsor
SWOG Sponsored
ClinicalTrials.gov ID NCT05568472
View on Clinical Trials.gov
|
S1703
Category
Breast Cancer
Full Name
Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Brief Description
A randomized trial that studies how well serum tumor marker directed disease monitoring works in monitoring patients with hormone receptor positive Her2 negative breast cancer that has spread to other places in the body.
Sponsor
SWOG Sponsored
ClinicalTrials.gov ID NCT03723928
View on Clinical Trials.gov
|
A012301
Category
Breast Cancer
Full Name
LoTam: A Randomized, Phase III Clinical Trial of Low-Dose Tamoxifen for Selected Patients With Molecular Low-Risk Early-Stage Breast Cancer
Brief Description
A phase III trial comparing the effect of low dose tamoxifen to usual hormonal therapy in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer.
Sponsor
SWOG Sponsored
ClinicalTrials.gov ID NCT06671912
View on Clinical Trials.gov
|
Gastrointestinal Cancer
NRG-GI008
Category
Gastrointestinal Cancer
Full Name
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Brief Description
This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.
Sponsor
NRG Oncology Sponsored
ClinicalTrials.gov ID NCT05174169
View on Clinical Trials.gov
|
|
|
Genitourinary Cancer
A031704
Category
Genitourinary Cancer
Full Name
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
Brief Description
PD-Inhibitor (Nivolumab) & Ipilimumab followed by Nivolumab vs VEGF TKI Cabozantinib with Nivolumab: A Phase III Trial in Metastatic Untreatet Renal Cell Cancer (PDIGREE)
Sponsor
NCI Sponsored
ClinicalTrials.gov ID NCT03793166
View on Clinical Trials.gov
|
|
|
Head & Neck Cancer
EA3161
Category
Head & Neck Cancer
Full Name
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer
Brief Description
A Phase II/III Randomized Study of Maintenance Nivolumab versus Observation in Patients with Locally Advanced, Intermediate-Risk HPV Positive Oropharyngeal Cancer
Sponsor
NCI Sponsored
ClinicalTrials.gov ID NCT03811015
View on Clinical Trials.gov
|
|
|
Multiple Disease Sites
Research Patient Registry
Category
Multiple Disease Sites
Full Name
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Brief Description
A research registry of the de-identified treatment and follow-up data of patients receiving stereotactic radiosurgery (SRS)/stereotactic body radiation therapy (SBRT), including CyberKnife (CK)
Sponsor
The Radiosurgery Society Sponsored
ClinicalTrials.gov ID NCT01885299
View on Clinical Trials.gov
|
|
|
Prostate
MEVPRO-1 (C2321014)
Category
Prostate Cancer
Full Name
A phase III, randomized, open-label study of PF-06821497 (Mevrometostat) in combination with Enzalutamide or Docetaxel for Metastatic Castration Resistant Prostate Cancer previously treated with Abiraterone Acetate.
Brief Description
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).
Sponsor
Pfizer Sponsored
ClinicalTrials.gov ID NCT06551324
View on Clinical Trials.gov
|
NRG-GU009
Category
Prostate Cancer
Full Name
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial
Brief Description
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
Sponsor
NRG Sponsored
ClinicalTrials.gov ID NCT04513717
View on Clinical Trials.gov
|
NRG-GU010
Category
Prostate Cancer
Full Name
Two Studies for Patients with Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients with a Low Gene Risk Score and Testing a More Intense Treatment for Patients with a Higher Gene Risk Score.
Brief Description
Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE)
Sponsor
NRG Sponsored
ClinicalTrials.gov ID NCT05050084
View on Clinical Trials.gov
|
OPTYX Registry
Category
Prostate Cancer
Full Name
A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX (OPTYX).
Brief Description
The goal of this study is to generate real-world evidence about the safety and effectiveness of ORGOVYX in patients with prostate cancer in routine clinical care and the clinical course during treatment with and following cessation of ORGOVYX.
Sponsor
Sumitomo Pharma Switzerland GmbH Sponsored
ClinicalTrials.gov ID NCT05467176
View on Clinical Trials.gov
|
|
|